| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701690 | Journal of Thoracic Oncology | 2017 | 35 Pages |
Abstract
A subset of SCLCs is characterized by positive PD-L1 and/or mRNA expression in tumor cells. Higher PD-L1 and mRNA expression correlate with more infiltration of TIICs. The prevalence of PD-L1 in SCLC is lower than that published for NSCLC. The predictive role of PD-L1 expression in SCLC treatment remains to be established.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hui MD, PhD, Cory PhD, Andrzej MD, PhD, Theresa A. MD, PhD, Piotr MD, Daniel C. PhD, Xian MS, Dexiang PhD, Kim MS, Ashley A. MS, Christopher J. PhD, Rafal MD, PhD, Caicun MD, PhD, Maen MD, Donald MD, Sharon MD, Marc MD, William MD, Fred R. MD, PhD,